Discover Biotech Webinar Pharma FDA & EMA ONCOLife Contact

ONCOLife Issues

February 2024

April 2024

May 2024

June 2024

October 2024

ONCOLife Articles

Novel Biomarker-Driven Treatments with ADCs in NSC Lung Cancer Management

5 November 2024

Antibody-drug conjugates (ADCs) represent a significant breakthrough in oncology, offering targeted treatments, especially for lung cancer. In this insightful interview with Dr. Nicolas Girard, we explore the evolving role of ADCs in treating non-small cell l...

Merlin Molecular Test Offers Hope for Melanoma Patients by Reducing Unnecessary Surgeries

Biotech | 11 October 2024

Bayer Expands Precision Oncology Portfolio with MOMA Therapeutics' KNOMATIC Platform

ONCOLife | 9 October 2024

The Next Generation of ADCs and the Potential of ABBV-400 in Lung Cancer Treatment

ONCOLife | 9 October 2024

The LUMINOSITY Trial And Exploring Novel Biomarker Targets in the Future of ADCs for NSCLC

ONCOLife | 7 October 2024

The Future of Oncolytic Viruses and Their Role in Cancer Treatment

ONCOLife | 3 October 2024

ESMO 2024: BRAFTOVI and MEKTOVI Extend Survival in Rare Mutant Lung Cancer

ESMO 2024: Novartis's Kisqali Reduces Breast Cancer Recurrence Risk by 28.5%

Clinical Trials

16 September 2024

The OVATION 2 Study and the Novel Immunotherapy IMNN-001 for Ovarian Cancer

ONCOLife

12 September 2024

European Commission Approves BRAFTOVI and MEKTOVI for Lung Cancer

ONCOLife

4 September 2024

Exploring The Potential of Cytokine Therapies to Transform Cancer Treatment

ONCOLife

29 August 2024


About Image

About ONCOLife

ONCOLife as a cutting-edge oncology magazine designed for oncologists and health professionals. It has flexible format, available both in print and online formats in the US and EU, ONCOLife is dedicated to covering key developments in the field of oncology. We delve into the stories behind significant clinical research and drug developments, highlight the latest news, and offer exclusive interviews.